PER 34.1% 8.9¢ percheron therapeutics limited

DMD Phase 2 Results in Q4 = Potential 5000% Gem, page-99

  1. 35,752 Posts.
    lightbulb Created with Sketch. 554
    Also be interesting to see Sarepta’s quarterly tomorrow night and update on their 14 other DMD programs.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.